Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Nov 2021 PLoS Pathog Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials Autoren Fischinger S et al. Nov 2021 Cancers Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma Autoren Klöhn M et al. Nov 2021 Microorganisms Cell Culture Isolation and Whole Genome Characterization of Hepatitis E Virus Strains from Wild Boars in Germany Autoren Schilling-Loeffler K et al. Nov 2021 Cells Characterization of RNA Sensing Pathways in Hepatoma Cell Lines and Primary Human Hepatocytes Autoren Nicolay W et al. Nov 2021 Vaccines (Basel) Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview Autoren Al-Karmalawy AA et al. Nov 2021 Int J Mol Sci COX Inhibitory and Cytotoxic Naphthoketal-Bearing Polyketides from Sparticola junci Autoren Garcia KYM et al. Nov 2021 Viruses Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524 Autoren Krentz D et al. Nov 2021 Cells Hepatitis-D Virus Infection Is Not Impaired by Innate Immunity but Increases Cytotoxic T-Cell Activity Autoren Altstetter SM et al. Nov 2021 Vaccines (Basel) Improving Therapeutic Vaccination against Hepatitis B-Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection Autoren Knolle PA et al. Nov 2021 Viruses In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity Autoren Manske K et al. Nov 2021 Pathogens Molecular Evidence for Flea-Borne Rickettsiosis in Febrile Patients from Madagascar Autoren Keller C et al. Nov 2021 J Clin Med Phantosmia, Parosmia, and Dysgeusia Are Prolonged and Late-Onset Symptoms of COVID-19 Autoren Schambeck SE et al. Nov 2021 Eur Respir J A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany Autoren Bahrs C et al. Nov 2021 Med Vet Entomol Artificial resting sites: An alternative sampling method for adult mosquitoes Autoren Jaworski L et al. Nov 2021 Lancet Infect Dis Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial Autoren Kremsner PG et al. Nov 2021 Sci Immunol Keratinocyte-intrinsic BCL10/MALT1 activity initiates and amplifies psoriasiform skin inflammation Autoren Kurgyis Z et al. Nov 2021 Nat Commun NUDT2 initiates viral RNA degradation by removal of 5'-phosphates Autoren Laudenbach BT et al. Nov 2021 Viruses (Basel) A rapid point-of-care test for the serodiagnosis of hepatitis delta virus infection Autoren Lempp FA et al. Nov 2021 BMC Public Health Funding patterns for biomedical research and infectious diseases burden in Gabon Autoren Adegnika OS et al. Nov 2021 mSphere Characterization of Amino Acid Substitutions in the Two-Component Regulatory System AdeRS Identified in Multidrug-Resistant Acinetobacter baumannii Autoren Lucaßen K et al. Nov 2021 BMJ Open Evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial Autoren González R et al. Nov 2021 mSphere High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study Autoren Moreira-Soto A et al. Nov 2021 iScience Fluvastatin mitigates SARS-CoV-2 infection in human lung cells Autoren Zapatero-Belinchón FJ et al. Nov 2021 JMIR Form Res Telemedicine-Guided Self-Collection Approach for PCR-Based SARS-CoV-2 Testing: Comparative Study Autoren Würstle S et al. Nov 2021 Proc Natl Acad Sci U S A THCz: Small molecules with antimicrobial activity that block cell wall lipid intermediates Autoren Reithuber E et al. Pagination Previous page ‹‹ Seite 105 Seite 106 Seite 107 Seite 108 Current page 109 Seite 110 Seite 111 Seite 112 Seite 113 Seite 105 Seite 106 Seite 107 Seite 108 Seite 109 Seite 110 Seite 111 Seite 112 Seite 113 Next page ››
Nov 2021 PLoS Pathog Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials Autoren Fischinger S et al.
Nov 2021 Cancers Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma Autoren Klöhn M et al.
Nov 2021 Microorganisms Cell Culture Isolation and Whole Genome Characterization of Hepatitis E Virus Strains from Wild Boars in Germany Autoren Schilling-Loeffler K et al.
Nov 2021 Cells Characterization of RNA Sensing Pathways in Hepatoma Cell Lines and Primary Human Hepatocytes Autoren Nicolay W et al.
Nov 2021 Vaccines (Basel) Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview Autoren Al-Karmalawy AA et al.
Nov 2021 Int J Mol Sci COX Inhibitory and Cytotoxic Naphthoketal-Bearing Polyketides from Sparticola junci Autoren Garcia KYM et al.
Nov 2021 Viruses Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524 Autoren Krentz D et al.
Nov 2021 Cells Hepatitis-D Virus Infection Is Not Impaired by Innate Immunity but Increases Cytotoxic T-Cell Activity Autoren Altstetter SM et al.
Nov 2021 Vaccines (Basel) Improving Therapeutic Vaccination against Hepatitis B-Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection Autoren Knolle PA et al.
Nov 2021 Viruses In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity Autoren Manske K et al.
Nov 2021 Pathogens Molecular Evidence for Flea-Borne Rickettsiosis in Febrile Patients from Madagascar Autoren Keller C et al.
Nov 2021 J Clin Med Phantosmia, Parosmia, and Dysgeusia Are Prolonged and Late-Onset Symptoms of COVID-19 Autoren Schambeck SE et al.
Nov 2021 Eur Respir J A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany Autoren Bahrs C et al.
Nov 2021 Med Vet Entomol Artificial resting sites: An alternative sampling method for adult mosquitoes Autoren Jaworski L et al.
Nov 2021 Lancet Infect Dis Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial Autoren Kremsner PG et al.
Nov 2021 Sci Immunol Keratinocyte-intrinsic BCL10/MALT1 activity initiates and amplifies psoriasiform skin inflammation Autoren Kurgyis Z et al.
Nov 2021 Nat Commun NUDT2 initiates viral RNA degradation by removal of 5'-phosphates Autoren Laudenbach BT et al.
Nov 2021 Viruses (Basel) A rapid point-of-care test for the serodiagnosis of hepatitis delta virus infection Autoren Lempp FA et al.
Nov 2021 BMC Public Health Funding patterns for biomedical research and infectious diseases burden in Gabon Autoren Adegnika OS et al.
Nov 2021 mSphere Characterization of Amino Acid Substitutions in the Two-Component Regulatory System AdeRS Identified in Multidrug-Resistant Acinetobacter baumannii Autoren Lucaßen K et al.
Nov 2021 BMJ Open Evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial Autoren González R et al.
Nov 2021 mSphere High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study Autoren Moreira-Soto A et al.
Nov 2021 iScience Fluvastatin mitigates SARS-CoV-2 infection in human lung cells Autoren Zapatero-Belinchón FJ et al.
Nov 2021 JMIR Form Res Telemedicine-Guided Self-Collection Approach for PCR-Based SARS-CoV-2 Testing: Comparative Study Autoren Würstle S et al.
Nov 2021 Proc Natl Acad Sci U S A THCz: Small molecules with antimicrobial activity that block cell wall lipid intermediates Autoren Reithuber E et al.
